World Health Organization Approves Corgenix's Ebola Test, Shares Spike Higher

by Jayson Derrick

February 20, 2015 11:19 AM | 1 min read | Make a Comment

Shares of

Corgenix Medical CorporationCONX

spiked higher by more than 7 percent on Friday after the

World Health Organization approved the company's 15-minute Ebola test. Corgenix Medical's Ebola test is less accurate than the standard PCR test, but is easy to perform, does not require electricity and offers results within 15 minutes, according to World Health Official spokesman Tarik Jasarevic. The rollout of the test kits will not begin immediately as the company is still working out costing and needs additional time to complete administrate procedures with the U.S. Food and Drug Administration. Shares traded recently at $0.28, up $0.02 (7.6 percent).

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: News Health Care FDA General Corgenix Medical Ebola Tarik Jasarevic World Health Organization

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Benzinga.com on devices